Axsome Therapeutics (AXSM) Q2 2025 Earnings Call Transcript

The transcript of Axsome Therapeutics' second-quarter earnings call for 2025 is available, featuring remarks from CEO Herriot Tabuteau and other executives. The company provided an update on its business performance and outlined forward-looking statements regarding clinical trials, regulatory plans, and commercial strategies.

By Motley Fool Transcribing, The Motley Fool May 4, 2026 38 min read · Yahoo Finance · May 4, 2026, 15:35 UTC

Axsome Therapeutics (AXSM) Q2 2025 Earnings Call Transcript

Tickers: $AXSM

Topics: business update clinical trials financial results

Read the full article at Yahoo Finance

More World news

Pomerantz Law Firm Investigates Boston Scientific Following Q3 Earnings Miss and Guidance Downgrade PR Newswire · November 12, 2026, 15:35 UTC
Jensen Huang Concludes 33-Year Tenure as CEO of Nvidia Seeking Alpha · November 12, 2026, 15:29 UTC
Metalla Royalty & Streaming Reports Q3 Revenue Growth and Increased Adjusted EBITDA Seeking Alpha · November 12, 2026, 15:26 UTC
Fed Governor Michael Barr Warns AI Market Concentration Could Drive Income Inequality Seeking Alpha · November 12, 2026, 15:27 UTC
Jefferies Upgrades Pattern Group (PTRN) Following Strong Brand Acquisition Performance Seeking Alpha · November 12, 2026, 15:27 UTC
Pomerantz Law Firm Investigates Six Flags Entertainment Corporation Following Fatal Roller Coaster Accident PR Newswire · November 12, 2026, 15:30 UTC
SpaceX Partners with Qualcomm to Launch Starlink Mobile Cellular Service Motley Fool · November 12, 2026, 15:21 UTC
Blast Resources Appoints Andy Yackulic as CEO to Lead Uranium Exploration PR Newswire · November 12, 2026, 15:26 UTC
FMC Corporation Shares Decline 13% in Thursday Trading Seeking Alpha · November 12, 2026, 15:22 UTC
U.S. Stock Indices Decline Following Nvidia CEO Jensen Huang's Resignation Seeking Alpha · November 12, 2026, 15:23 UTC